Background: Emotional intelligence (EI) can help perceive, understand, and manage emotions and positively impact performance in any profession, including pharmacists, and consequently may have positive influence on patient-related outcomes. Although there is strong body of evidence suggesting that developing EI in health professionals (HPs) can increase their capacity to successfully communicate and build relationships with patients, thus increasing patient satisfaction, little is known about it in pharmaceutical care (PhC).
Objectives: This review aimed to synthesize available data on the probable impact of EI on PhC.
Methods: PubMed, Web of Science, and Embase databases were searched for papers in English dated between January 2000 and June 2021. Quantitative, qualitative, or mixed method studies on EI and PhC that involved practicing pharmacists were included.
Results: The inclusion criteria were met by 4 papers only. One reported positive impact of EI in reducing the negat...ive correlation between autistic-like traits and empathy among hospital pharmacists. One study demonstrated that EI levels can be significantly enhanced through pharmacy leadership programs. Another study established a positive correlation between EI and entrepreneurial orientation in practicing community pharmacists. Higher EI scores were predictors of increased work innovation, proactivity, and risk-taking levels. One study reported comparative EI data between different HPs and found pharmacists' superiority in the EI subdomains of self-awareness, self-motivation, and social skills.
Conclusion: Additional research is required to provide evidence on how EI and EI development programs can add value to the provision of PhC. Processes and resources ought to be developed and secured to support the implementation and follow-up of such programs to bring long-term benefits to practicing pharmacists and consequently positively impacting patient-reported health outcomes.
Source:
Journal of the American Pharmacists Association, 2022, 62, 4, 1133-1141
TY - JOUR
AU - Senćanski, Dejan
AU - Tadić, Ivana
AU - Marinković, Valentina
PY - 2022
UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4210
AB - Background: Emotional intelligence (EI) can help perceive, understand, and manage emotions and positively impact performance in any profession, including pharmacists, and consequently may have positive influence on patient-related outcomes. Although there is strong body of evidence suggesting that developing EI in health professionals (HPs) can increase their capacity to successfully communicate and build relationships with patients, thus increasing patient satisfaction, little is known about it in pharmaceutical care (PhC).
Objectives: This review aimed to synthesize available data on the probable impact of EI on PhC.
Methods: PubMed, Web of Science, and Embase databases were searched for papers in English dated between January 2000 and June 2021. Quantitative, qualitative, or mixed method studies on EI and PhC that involved practicing pharmacists were included.
Results: The inclusion criteria were met by 4 papers only. One reported positive impact of EI in reducing the negative correlation between autistic-like traits and empathy among hospital pharmacists. One study demonstrated that EI levels can be significantly enhanced through pharmacy leadership programs. Another study established a positive correlation between EI and entrepreneurial orientation in practicing community pharmacists. Higher EI scores were predictors of increased work innovation, proactivity, and risk-taking levels. One study reported comparative EI data between different HPs and found pharmacists' superiority in the EI subdomains of self-awareness, self-motivation, and social skills.
Conclusion: Additional research is required to provide evidence on how EI and EI development programs can add value to the provision of PhC. Processes and resources ought to be developed and secured to support the implementation and follow-up of such programs to bring long-term benefits to practicing pharmacists and consequently positively impacting patient-reported health outcomes.
PB - Elsevier B.V.
T2 - Journal of the American Pharmacists Association
T1 - Emotional intelligence and pharmaceutical care: A systematic review
VL - 62
IS - 4
SP - 1133
EP - 1141
DO - 10.1016/j.japh.2022.02.019.
ER -
@article{
author = "Senćanski, Dejan and Tadić, Ivana and Marinković, Valentina",
year = "2022",
abstract = "Background: Emotional intelligence (EI) can help perceive, understand, and manage emotions and positively impact performance in any profession, including pharmacists, and consequently may have positive influence on patient-related outcomes. Although there is strong body of evidence suggesting that developing EI in health professionals (HPs) can increase their capacity to successfully communicate and build relationships with patients, thus increasing patient satisfaction, little is known about it in pharmaceutical care (PhC).
Objectives: This review aimed to synthesize available data on the probable impact of EI on PhC.
Methods: PubMed, Web of Science, and Embase databases were searched for papers in English dated between January 2000 and June 2021. Quantitative, qualitative, or mixed method studies on EI and PhC that involved practicing pharmacists were included.
Results: The inclusion criteria were met by 4 papers only. One reported positive impact of EI in reducing the negative correlation between autistic-like traits and empathy among hospital pharmacists. One study demonstrated that EI levels can be significantly enhanced through pharmacy leadership programs. Another study established a positive correlation between EI and entrepreneurial orientation in practicing community pharmacists. Higher EI scores were predictors of increased work innovation, proactivity, and risk-taking levels. One study reported comparative EI data between different HPs and found pharmacists' superiority in the EI subdomains of self-awareness, self-motivation, and social skills.
Conclusion: Additional research is required to provide evidence on how EI and EI development programs can add value to the provision of PhC. Processes and resources ought to be developed and secured to support the implementation and follow-up of such programs to bring long-term benefits to practicing pharmacists and consequently positively impacting patient-reported health outcomes.",
publisher = "Elsevier B.V.",
journal = "Journal of the American Pharmacists Association",
title = "Emotional intelligence and pharmaceutical care: A systematic review",
volume = "62",
number = "4",
pages = "1133-1141",
doi = "10.1016/j.japh.2022.02.019."
}
Senćanski, D., Tadić, I.,& Marinković, V.. (2022). Emotional intelligence and pharmaceutical care: A systematic review. in Journal of the American Pharmacists Association
Elsevier B.V.., 62(4), 1133-1141.
https://doi.org/10.1016/j.japh.2022.02.019.
Senćanski D, Tadić I, Marinković V. Emotional intelligence and pharmaceutical care: A systematic review. in Journal of the American Pharmacists Association. 2022;62(4):1133-1141.
doi:10.1016/j.japh.2022.02.019. .
Senćanski, Dejan, Tadić, Ivana, Marinković, Valentina, "Emotional intelligence and pharmaceutical care: A systematic review" in Journal of the American Pharmacists Association, 62, no. 4 (2022):1133-1141,
https://doi.org/10.1016/j.japh.2022.02.019. . .
